The Code of Federal Regulations of the United States of AmericaU.S. Government Printing Office, 1989 The Code of Federal Regulations is the codification of the general and permanent rules published in the Federal Register by the executive departments and agencies of the Federal Government. |
No grāmatas satura
1.5. rezultāts no 100.
9. lappuse
... withdrawn . ( d ) After September 29 , 1977 , animal drugs that contain hexachlorophene other than for preservative ... withdraw approval of new animal drug applications will be initiated if supple- mental new animal drug applications ...
... withdrawn . ( d ) After September 29 , 1977 , animal drugs that contain hexachlorophene other than for preservative ... withdraw approval of new animal drug applications will be initiated if supple- mental new animal drug applications ...
82. lappuse
... withdraw approval of new - drug applications under the provisions of section 505 of the act . Antibiotic preparations , other than those for topical and ophthalmic application in food - producing animals , which are not covered by food ...
... withdraw approval of new - drug applications under the provisions of section 505 of the act . Antibiotic preparations , other than those for topical and ophthalmic application in food - producing animals , which are not covered by food ...
85. lappuse
... withdraw the ap- proval of the application , as provided in § 514.200 of this chapter . ( e ) Upon written request of the ap- plicant stating reasonable grounds therefor , the Commissioner will make available any information in posses ...
... withdraw the ap- proval of the application , as provided in § 514.200 of this chapter . ( e ) Upon written request of the ap- plicant stating reasonable grounds therefor , the Commissioner will make available any information in posses ...
87. lappuse
... withdrawn under § 514.115 of this chapter on the basis of a re- quest for its withdrawal submitted in writing by a person holding an ap- proved application . Such withdrawal of approval will be made on the ground that the drug subject ...
... withdrawn under § 514.115 of this chapter on the basis of a re- quest for its withdrawal submitted in writing by a person holding an ap- proved application . Such withdrawal of approval will be made on the ground that the drug subject ...
90. lappuse
( e ) The Commissioner will initiate action to withdraw approval of a new animal drug application or terminate an ... withdrawal period which has been established based upon data submitted to the Commissioner and found satisfactory for ...
( e ) The Commissioner will initiate action to withdraw approval of a new animal drug application or terminate an ... withdrawal period which has been established based upon data submitted to the Commissioner and found satisfactory for ...
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
82 Stat administered amended Amount amoxicillin Amprolium animal feed antibiotic approved aqueous bacitracin bacterial batch for potency body weight cattle chapter chloramphenicol chlortetracycline cloxacillin coccidiosis coccidiosis caused coli days before slaughter dihydrostreptomycin dosage forms dose Drug Administration edible tissues erythromycin Federal law restricts Feed continuously feed efficiency flavor Food and Drug g/ton gentamicin grams hydrochloride Indications ingredient injection labeling lasalocid licensed veterinarian Limitations medicated feed ment milk milligrams milligrams per pound milliliter monensin mycin NAS/NRC neomycin novobiocin ointment oral oxytetracycline P.O. Box package paragraph percent polymyxin pound of body procaine penicillin Proceed as directed Related tolerances Requirements for certification residues restricts this drug retort roxarsone sample scheduled process sodium sole ration sole source Specifications Sponsor Standards of identity statement sterile streptomycin strongyles submitted Subpart sulfamethazine sulfate swine tablets tains tests and assays Tests and methods tetracycline tion treat treatment tylosin veterinarian
Populāri fragmenti
77. lappuse - The composition of which is such that such drug, as a result of investigations to determine its safety and effectiveness for use under such conditions, has become so recognized but which has not, otherwise than in such investigations, been used to a material extent or for a material time under such conditions...
131. lappuse - ... substantial evidence" means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling...
19. lappuse - ZIP code; however, the street address may be omitted if it is shown in a current city directory or telephone directory. The requirement for inclusion of the ZIP code shall apply only to consumer commodity labels developed or revised after the effective date of this section. In the case of nonconsumer packages, the ZIP code shall appear either on the label or the labeling (including invoice). (e) If a person manufactures, packs, or distributes a food at a place other than his principal place of business,...
17. lappuse - If it is an imitation of another food, unless its label bears, in type of uniform size and prominence, the word "imitation" and, immediately thereafter, the name of the food imitated.
130. lappuse - Secretary pursuant to subsection (b), do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling...
630. lappuse - In the synthesis, extraction. or other method of preparation, regardless of whether they undergo chemical change In the process. Each substance should be Identified by Its common English name and complete chemical name, using structural formulas when necessary for specific Identification. If any proprietary preparation Is used as a component, the proprietary name should be followed by a complete quantitative statement ot composition.
134. lappuse - ... were not made adequate within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of; or (3) That on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the labeling of such drug...
29. lappuse - ... or more) followed in parentheses by a declaration in pounds for weight units, with any remainder in terms of ounces or common or decimal fractions of the pound...
22. lappuse - natural flavor" or "natural flavoring" means the essential oil, oleoresin, essence or extractive, protein hydrolysate, distillate, or any product of roasting, heating or enzymolysis, which contains the flavoring constituents derived from a spice, fruit or fruit juice, vegetable or vegetable juice, edible yeast, herb, bark, bud, root, leaf or similar plant material, meat, seafood, poultry, eggs, dairy products, or fermentation products thereof, whose significant function in food is flavoring rather...
134. lappuse - New evidence not contained in such application or not available to the Secretary until after such application was approved, or tests by new methods, or tests by methods not deemed reasonably applicable when such application was approved, evaluated together with the evidence available to the Secretary when the application was approved...